New Joint Venture To Build Asia’s Largest Influenza Vaccine Facility
Microbix, (TSX:MBX) a Canadian developer of a patented technology that increases influenza vaccine yields, has signed a joint venture agreement with the Hunan Biopharmaceutical Co. Ltd. (a Chinese Hunan Province state-owned enterprise) for initial financing to build Asia’s largest influenza vaccine production facility and the third largest vaccine plant in the world. A newly formed [...]
DNA Vaccine Potential
Inovio has created a novel platform for developing and delivering “universal” DNA-based vaccines against diseases such as influenza, HIV, malaria, dengue, and cervical cancer. Inovio’s universal vaccines have shown preclinical results indicating their potential to protect against new, unknown strains of an infectious disease such as the currently circulating H1N1 “swine flu.”
Dr. J. Joseph [...]
U.S. Government Funds Vaccine Adjuvant Development
U.S. government, through the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded six new research contracts to discover and characterize novel adjuvants, substances that can be added to vaccines to enhance the protective immune response they induce.
Global Pandemic Influenza Preparedness Market Forecast 2010-2015
Currently, the [...]
